Earlier this month Sachin Jain, CEO of SCAN Health Plan, a nonprofit Medicare Advantage company, provided some refreshing straight talk on what is wrong with MA while stressing that it is far better than traditional Medicare for seniors.
At Medicarians 2025, MedCity News Editor-in-Chief Arundhati Parmar explored the state of AgeTech venture capital with three investors. The panelists agreed that despite growing clear opportunities, the AgeTech market currently lacks the dedicated funding, proven business models and major success stories needed for it to take off.
Help shape the future of healthcare benefits by sharing your insights.
This is not just about today’s older adults — it’s about the next 50 years. If we design a smarter, more sustainable system now, we will all benefit when our time comes.
They work in neighborhood clinics, community-based organizations, churches, housing facilities, and schools, or engage by phone or video calls. Their approach is based on local context and guided by culturally sensitive, person-centered strategies.
Reporting quality on all beneficiaries marks a major shift, requiring thoughtful preparation and strategic planning. If your Accountable Care Organization (ACO) hasn’t started yet, don’t worry — there’s still time to get on track.
The impact of private equity investments in healthcare under the new administration is multifaceted. While deregulation and business-friendly policies could stimulate investment and drive innovation, there are significant concerns about the potential negative effects on healthcare quality and access.
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
The Uno Savings Guide is a free resource that helps people check their eligibility for financial benefit programs, like Medicaid, Medicare Savings Programs and SNAP.
Several healthcare provisions, including drug reforms, were left out of the government funding bill, angering some healthcare leaders.
Several healthcare leaders are supporting the Biden-Harris administration’s proposed rule to expand Medicare and Medicaid coverage of GLP-1 medications for obesity treatment.
For those who rely on these treatments, affordable medication access is a matter of health, freedom, and dignity, and their mechanisms and outcomes are non-partisan.
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.
On the surface, it sounds positively delightful - who wouldn't want to help dear grandma avoid the nursing home? But as is often the case with these sweeping government proposals, the devil is in the details.
Doctor’s offices are the front door of the American healthcare system. We owe it to them to support H.R. 2474 and put an end to annual Congressional stop-gap spending bills.
The industry is increasingly under attack by lawmakers from both parties for drug prices most Americans regard as unreasonable, so the election outcome could be pivotal to drug companies’ fortunes.
If enacted, the codes will represent the first major step toward broad-based reimbursement for digital therapeutics, and acknowledgement that CMS recognizes the substantial role new digital solutions can provide.
Fair Square Medicare launched a new generative AI platform called Vox. It's meant to be used by Medicare carriers and brokerages and has three main features: AI voice agents, generative AI-driven insights and AI-powered coaching.